Alzheimer's Disease Research Paper

There is currently no cure for Alzheimer’s disease, but there are many treatments to help ease the complications. Treatments include medication that will help cognitive function, low blood

Doctors do standard medical tests, such as blood and urine tests, to resolve other possible cause. Perform brain scans like magnetic resonance imaging (MRI) or computed tomography (CT). Conduct a memory test, problem solving, counting, and speech. Further, assessment and diagnosis can be done by the specialist including Geriatricians, Geriatric psychiatrists (specialize in the mental behavior of older adults), Neurologist (specialize abnormalities of the brain) and Neuropsychologist (who execute a memory test). A definite diagnosis is made only after death by a clinical measures and examination of the brain tissue during an

Doctors administer a variety of strategies to diagnose dementia (National Institute of Neurological Disorders and Stroke). It is extremely important that all treatable conditions first be ruled out, such as depression and Vitamin B12 deficiency, which can cause the same type of symptoms as dementia (National Institute of Neurological Disorders and Stroke). Timely and accurate diagnosis of dementia is extremely important for both the patient and their families because it allows early treatment of symptoms (National Institute of Neurological Disorders and Stroke). A variety of tests are used to aid in the diagnosis process, such as neurological evaluations, in which doctors look specifically at patients’ balance, sensory responses, reflexes, and various other functions (National

Subsequently, the full evaluation process that takes place also varies among individuals of different ages and their symptoms experienced (Shimada 47). In the cases of younger onset cognitive impairment with quick progression, an MRI scan and bloodwork are done (Lee et al. 155). From clear MRI scans and blood tests, potential reasonings for Alice’s symptoms, for example brain tumours, can be ruled out. As Alice’s cognitive decline continues, the next step is a PET scan to observe the brain at a molecular level in determining the amyloid levels in the

Investigate and clarify how the patient meets criteria for the disorder(s) as per the patient 's side effects and the criteria sketched out in the symptomatic manual.

Current Alzheimer's pharmaceuticals can help for a period with memory side effects and other intellectual changes. Two sorts of medications are at present used to treat subjective manifestations:

Even though it is the most common form of dementia, there is still not a single test that can identify the disease, and there is no definitive way to ensure the accuracy of the diagnosis why the person is still alive. Today, medical tests such as CT scans and MRIs can identify the disease with close to 90 percent accuracy, but the only way to be sure that somebody actually had Alzheimer's disease is through an analysis of brain tissue during an autopsy.

Alzheimer’s is a disease with many stages. It is a terrible, slow-progressing disease and few people know how it progresses, how it affects the family members, and the medical research being done to find a cure. It is very difficult to watch a loved one suffer with Alzheimer’s, however finding a cure could be in the near future.

Doctors usually use a lot of little tests to rule out other types of dementia. Methods used to rule out other diseases are brain imaging, biomarker test, testing proteins and spinal fluids. Those are all methods used by testing the patient's body, but there are many other tests that don't involve that kind of testing. Examples of this would be looking into patients’ family histories (because early onset Alzheimer's can be passed on), history of medicine they have taken or previous or current substance abuse that could make them more susceptible to Alzheimer's, or simply a mental status determination, during which the doctor would ask them questions, ask them to remember certain things, test ability to read and write, and attention span. Also, because Early Onset is diagnosed usually in the patients’ 30s, 40s, or 50s, age is also taken into consideration before diagnosing. All of these could lead to the diagnosis of Early Onset Alzheimer's.

When treating Alzheimer’s disease the main goals are to maintain mental function, manage behavioral symptoms, and slow or delay the disease. As of right now there is no cure for Alzheimer’s disease. There is also not much we understand about the disease or know its causes.

-People who have this disease have an early-onset type associated with genetic mutations. They are guaranteed to develop the disease. A trial conducted by the Dominantly Inherited Alzheimer is testing antibodies to beta-amyloid that can reduce the accumulation of beta-amyloid in the brains, and also prevent symptoms. These individuals are receiving antibodies before they develop

Alzheimer’s disease is a chronic continuous loss of neurons that usually starts slowly and gets worse over time. It is the cause of 60% to 70% of cases of dementia. This is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. In most cases, the first symptom usually occurs in mid-60s.

Alzheimer’s is a type of dementia that causes problems with memory, thinking and behavior. Currently, there is no cure. However, there are many clinical trials being done to find a way to slow down, or even cure, this disease.

Symptoms of Alzheimer's dementia include difficulty with many areas of mental functionality, including memory, language, perception, cognitive skills, emotional behavior, and changes in personality. The first sign of Alzheimer's dementia is forgetfulness.

Members of a family and close friends are more sensitive to the early signs of Alzheimer’s disease than traditional screening tests. The researchers from the University of Washington have developed the alternative approach to diagnostics of this disease which is based on questioning of the family or relatives of the patient. Such a questionnaire takes only some minutes and allows estimating cognitive changes which cause difficulties in accomplishment of daily activities. It is proved by the researches on the presence of biomarkers, such as abnormal levels of certain factors in a spinal liquid or Alzheimer’s plaques